EpCAM-specific CAR-expressing autologous T lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-013381
A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) specific for the antigen epithelial cell adhesion molecule (EpCAM), with potential immunostimulating and antineoplastic activities. Upon administration, the EpCAM-specific CAR-expressing autologous T lymphocytes specifically recognize and bind to EpCAM-expressing tumor cells, resulting in tumor cell lysis. EpCAM, a cell surface protein, is expressed by a variety of tumor cells.
| Identifier | MLC-T-ONC-013381 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | EpCAM-specific CAR autologous T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013381",
"term": "EpCAM-specific CAR-expressing autologous T lymphocytes",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) specific for the antigen epithelial cell adhesion molecule (EpCAM), with potential immunostimulating and antineoplastic activities. Upon administration, the EpCAM-specific CAR-expressing autologous T lymphocytes specifically recognize and bind to EpCAM-expressing tumor cells, resulting in tumor cell lysis. EpCAM, a cell surface protein, is expressed by a variety of tumor cells.",
"synonyms": [
"EpCAM-specific CAR autologous T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/epcam-specific-car-expressing-autologous-t-lymphocytes/"
}
Record 6,745 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.